Search Results

3PO 25mg  | ≥99%

CSNpharm

3PO inhibits recombinant PFKFB3 activity with IC50 of 25 μM, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.

More Information Supplier Page

3PO 50mg  | ≥99%

CSNpharm

3PO inhibits recombinant PFKFB3 activity with IC50 of 25 μM, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.

More Information Supplier Page

3PO 5mg  | ≥99%

CSNpharm

3PO inhibits recombinant PFKFB3 activity with IC50 of 25 μM, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.

More Information Supplier Page